GROW THE FULL POTENTIAL OF YOUR PRODUCT AT EVERY STAGE OF DEVELOPMENT
Maximize the value of your asset and take strategic steps to increase it using Facet’s expert asset valuation services.
LET’S WORK TOGETHER
Expert Guidance for Asset Growth
Facet Helps You Navigate the Critical Choices to Optimize Asset Value
At Facet Life Sciences, we specialize in helping small life sciences companies know and grow the full potential of their asset at every stage of development.
Know your asset value EARLY in the development process and grow asset value throughout the development life-cycle to achieve long-term success.
Whether your goal is to bring a product to market or prepare for a value-driven divestiture, Facet’s asset valuation services are designed to transform your product into a successful market-ready solution.
Your Journey, Simplified
Early Stage R&D
Evolving and Refining Market Understanding.
Late Stage R&D
Informing Late-Stage Development.
Launch Prep
Clarity of What is Valuable.
Launched
Market Understanding.
Established
Validation to Increase Market.
Maturity
Lifecycle Management.
Companies Must Understand How to Maximize Asset Value at Every Stage of Development
Early Stage R&D
Evaluating Unmet Needs and Prioritizing High-Value Opportunities
- Define unmet medical need and burden of illness, including disease prognosis/progression
- Natural history of disease
- Current medical practice and treatment algorithms/guidelines
- Patient and caregiver insight research
- Early indication valuation
- Market sizing and opportunity assessment
- Incidence, prevalence, duration of treatment
- Product and payer adoption strategy
- Competitive landscape analysis and mapping
- Early phase evidence planning
- Stakeholder insights and perceived value
- Health economics and outcomes research (HEOR)/Real-world evidence (RWE) planning
Late Stage
R&D Integrating Clinical, Regulatory, and Economic Strategies
- Use of real world data to inform late-stage trial design (i.e. refined patient populations with well identified inclusion/exclusion criteria, feasibility, assessment, and clinical endpoints)
- Clinical trial results informing product modeling, reimbursement strategy
- Stakeholder partnership
- Launch playbook
- Gap analysis of clinical data/evidence
- Value proposition development
Launch Prep
Transforming Clinical Success into Commercial Momentum
- Go-to-market / divestiture planning and execution
- Commercial differentiation and positioning
- Market access and distribution strategy development
- HCP and Payer communication strategy
- Revise value proposition & communication material
- Pricing and contracting strategy
- Provider and patient support programs
Launched
Launched Driving Market Adoption and Long-Term Success
- Expand Stakeholder Partnerships
- Refresh, revise HEOR, RWE data plan
- Payer Education
- Re-positioning research
- Monitor & track business metrics
Maturity
Expanding Lifecycle Management for Continued Success
- Repositioning competitor landscape changes/ strategy
- Development of communication activities for newer indications
- Product lifecycle strategy testing & ROI
- Loss of exclusivity strategy
- New formulation assessments
Our Comprehensive Asset Valuation Services Include:
End-to-End Support
From discovery to post-marketing, our tailored services guide you through every stage, ensuring strategic alignment, market readiness, and optimal valuation.
Market Assessment
Understand your product’s competitive landscape, including pricing, reimbursement trends, and market needs.
Regulatory Alignment
Align your commercial strategy with FDA requirements.
Investor Support
Secure investment early and align your development strategy with investor expectations.
Strategic Roadmapping
Define the best indications and development pathways to maximize return on investment (ROI).
Health Economics
Enhance and showcase the unique value of your product through strategic analysis of HEOR data.
Cost-Effective Modeling
Take control of pricing negotiations with payers using a strong, data-driven position.
Pricing & Reimbursement
Establish optimal pricing strategies for broad market access.
WHY CHOOSE FACET LIFE SCIENCES?
Your Success is Our Mission
At Facet, your success drives us. We form lasting partnerships, offering the expertise and tools needed to bring your product to divestiture or to market successfully. Join the many companies that have turned their innovative ideas into reality with Facet Life Sciences.
Specialized Expertise
We have over 300 years of combined experience guiding and supporting small companies into successfully divesting or bringing their products to market.
Tailored Solutions
Not all companies are the same. We develop custom strategies to ensure long term success for our clients that address their unique challenges and opportunities.
Cost-Effective Partnership
We provide high-impact, scalable services without the overhead of in-house staff.
Client Success Stories
"Facet proactively worked with us and FDA to design and implement a Phase 3 program that was manageable for a small company to conduct. Facet was a critical part of our NDA application strategy and used their expertise to author, finalize, submit, and shepherd our combination product NDA through the FDA review process."
"Facet’s innovative strategies got us to an open IND faster than we expected. What’s more, their dynamic approach and excellent working relationship with the FDA has us well positioned to progress our unique disease-modifying therapy."
"Facet helped our team achieve something unheard of in the psychedelics industry. Their strategic leadership and flawless tactical execution supported us from conception to successful IND-filing for a new chemical entity in 18 months."
"Facet took us from pivotal study database lock to NDA (approved) in six weeks."
Ready to Add Value to Your Asset?
Your company and your product deserves the best support. Contact us today to schedule a consultation and learn how our commercialization services can align your strategy for success.
Learn More About Our Unique Approach
gET sOCIAL